Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.
03:41
an hour ago
Trending
- Israel-Iran conflict continues but markets seem unfazed
- SoftBank raises $4.8 billion from T-Mobile share sale : Reuters
- SK Hynix rises to over 2-decade highs as parent group plans data center
- Pres. Trump meets with U.K. Prime Minister Starmer at G7 summit
- Pacifist Japan seems to be doubling down on arms exports
- 'Fast Money' traders talk Big Tech's Monday rally
- Eaton makes a move outside of the data center — plus, what’s new with Abbott Labs
- What’s likely to move the market
Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy
